Am. Hocking et al., EUKARYOTIC EXPRESSION OF RECOMBINANT BIGLYCAN - POSTTRANSLATIONAL PROCESSING AND THE IMPORTANCE OF SECONDARY STRUCTURE FOR BIOLOGICAL-ACTIVITY, The Journal of biological chemistry, 271(32), 1996, pp. 19571-19577
Biglycan is a small chondroitin sulfate proteoglycan found in many tis
sues and is structurally related to decorin, fibromodulin, and lumican
. The biological function of biglycan is poorly understood, although s
everal studies have indicated interaction with other extracellular mat
rix components, We have initiated studies of structural and functional
domains of biglycan by transient eukaryotic expression using the vacc
inia virus/T7 bacteriophage expression system, A recombinant vaccinia
virus, vBGN4 encoding the mature biglycan core protein as a polyhistid
ine fusion protein under control of the T7 phage promoter was expresse
d in HT-1080 cells and UMR106 cells, The structure of the recombinant
biglycan secreted by these cells was defined by analyzing molecules la
beled in the presence of [S-35]sulfate, [H-3]glucosamine, and [S-35]me
thionine. Glycoforms of biglycan were separated by imidazole gradient
elution, under non-denaturing conditions, and comprised: a large prote
oglycan form substituted with two chondroitin sulfate chains of molecu
lar mass similar to 34 kDa (HT-1080 cells) or similar to 40 kDa (UMR10
6 cells); a small proteoglycan form substituted with two chondroitin s
ulfate chains with a median molecular mass similar to 28 kDa; and a co
re protein form secreted devoid of glycosaminoglycan chains, All the g
lycoforms were substituted with two N-linked oligosaccharides, and the
disaccharide composition of the two glycosaminoglycan populations wer
e identical, Approximately 70% of the recombinant biglycan secreted by
HT-1080 cells was substituted with chondroitin sulfate chains, wherea
s about 50% of the biglycan expressed by UMR106 cells was substituted
with chondroitin sulfate chains, Infection with vBGN4 in both HT-1080
and UMR106 cells resulted in the production of approximately 10 mg of
biglycan/10(9) cells per 24 h, The native recombinant biglycan was sho
wn to bind to collagen type V and the complement protein, Clq, However
, when the secondary structure of recombinant biglycan was disrupted b
y exposure to 4 hi guanidine hydrochloride, the affinity for collagen
type V was dramatically reduced. These data demonstrate the importance
of secondary structure to the function of this small proteoglycan.